TFCM
MBOT icon

Taylor Frigon Capital Management’s Microbot Medical MBOT Stock Holding History

Taylor Frigon Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,500
Closed -$20.5K – 87
2023
Q4 		$20.5K Hold
12,500
– – 0.01% 87
2023
Q3 		$17.4K Buy
+12,500
New +$27.1K 0.01% 88

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Taylor Frigon Capital Management's MBOT Position: Q1 2024 in Review

Taylor Frigon Capital Management sold out of Microbot Medical (MBOT) in Q1 2024, closing a stake of 12,500 shares — an estimated $20.5K sold.

Taylor Frigon Capital Management first reported a position in MBOT in Q3 2023 and held it in 2 quarters. The position peaked at $20.5K in Q4 2023. 33 funds tracked by Wall St. Rank hold MBOT as of Q1 2024.

  • Taylor Frigon Capital Management reported no remaining Microbot Medical position as of Q1 2024 after selling out during the quarter.
  • Taylor Frigon Capital Management sold 12,500 Microbot Medical shares in Q1 2024, an estimated $20.5K.
  • Taylor Frigon Capital Management first reported a position in Microbot Medical in Q3 2023 and held it in 2 quarters.
  • Taylor Frigon Capital Management's Microbot Medical position peaked at $20.5K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2024.

Based on Taylor Frigon Capital Management's 13F filing for Q1 2024, filed 19 Apr 2024.